Cimit News
Funding Opportunity: Blueprint Medtech Winter Award Competition
CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, are accepting pre-proposals from academic and industry applicants who have emerging preventative, therapeutic, or diagnostic medical devices focused on disorders of the nervous system.
Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization.
A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space.
Award Types
Optimizer Awards:
- Up to $500,000 in direct costs per year for up to 4 years.
- Ongoing mentorship from experienced executives.
- Comprehensive resources and support services.
Seedling Awards:
- 6-months of support.
- A $25,000 stipend.
- An additional $25,000 to hire subject matter experts.
- Ongoing mentorship to overcome identified gaps.
The deadline for this opportunity has passed.
CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, are accepting pre-proposals from academic and industry applicants who have emerging preventative, therapeutic, or diagnostic medical devices focused on disorders of the nervous system.
Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization.
A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space.
Award Types
Optimizer Awards:
- Up to $500,000 in direct costs per year for up to 4 years.
- Ongoing mentorship from experienced executives.
- Comprehensive resources and support services.
Seedling Awards:
- 6-months of support.
- A $25,000 stipend.
- An additional $25,000 to hire subject matter experts.
- Ongoing mentorship to overcome identified gaps.
The deadline for this opportunity has passed.